Annual Total Debt
$62.47 M
+$35.55 M+132.08%
31 December 2022
Summary:
Eagle Pharmaceuticals annual total debt is currently $62.47 million, with the most recent change of +$35.55 million (+132.08%) on 31 December 2022. During the last 3 years, it has risen by +$28.21 million (+82.34%). EGRX annual total debt is now at all-time high.EGRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$71.61 M
-$6.30 M-8.09%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly total debt is currently $71.61 million, with the most recent change of -$6.30 million (-8.09%) on 30 June 2023. EGRX quarterly total debt is now -52.73% below its all-time high of $151.50 million, reached on 31 March 2020.EGRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +82.3% | +125.7% |
| 5 y5 years | +40.7% | +62.8% |
EGRX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +132.1% | -8.1% | +166.1% |
| 5 y | 5 years | at high | +132.1% | -52.7% | +166.1% |
| alltime | all time | at high | -52.7% |
Eagle Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $71.61 M(-8.1%) |
| Mar 2023 | - | $77.92 M(+21.7%) |
| Dec 2022 | $62.47 M(+132.1%) | $64.00 M(-1.2%) |
| Sept 2022 | - | $64.77 M(+20.9%) |
| June 2022 | - | $53.59 M(+94.0%) |
| Mar 2022 | - | $27.63 M(+2.6%) |
| Dec 2021 | $26.92 M(-21.4%) | $26.92 M(-15.2%) |
| Sept 2021 | - | $31.74 M(-6.4%) |
| June 2021 | - | $33.91 M(-6.0%) |
| Mar 2021 | - | $36.06 M(+5.3%) |
| Dec 2020 | $34.26 M(-17.6%) | $34.26 M(-12.1%) |
| Sept 2020 | - | $38.98 M(-3.4%) |
| June 2020 | - | $40.37 M(-73.4%) |
| Mar 2020 | - | $151.50 M(+264.6%) |
| Dec 2019 | $41.56 M(-6.4%) | $41.56 M(-5.5%) |
| Sept 2019 | - | $44.00 M(+1.3%) |
| June 2019 | - | $43.45 M(+3.5%) |
| Mar 2019 | - | $42.00 M(-5.4%) |
| Dec 2018 | $44.41 M(-7.1%) | $44.41 M(+0.2%) |
| Sept 2018 | - | $44.31 M(-5.2%) |
| June 2018 | - | $46.72 M(-2.4%) |
| Mar 2018 | - | $47.87 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $47.78 M(>+9900.0%) | $47.78 M(-2.4%) |
| Sept 2017 | - | $48.94 M(>+9900.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sept 2014 | $0.00(0.0%) | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00 |
| Sept 2012 | $8.57 M | - |
FAQ
- What is Eagle Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual total debt?
The current annual total debt of EGRX is $62.47 M
What is the all time high annual total debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual total debt is $62.47 M
What is Eagle Pharmaceuticals quarterly total debt?
The current quarterly total debt of EGRX is $71.61 M
What is the all time high quarterly total debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly total debt is $151.50 M